Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi US Tech 100 Equal Weight UCITS ETF DR - USD (D)
WEBA · IE000Y9MG996 · class UCITS ETF DR - USD · USD · domicile Ireland
Equity · United States · Technology · Risk paritySFDR art. 6
Index tracked: Solactive United States Technology 100 Equal Weight Index NTR
- TER
- 0.07%+ trans. 0.02%
- Fund size
- 45 m EUR
- Tracking difference
- —not computable
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingannual
Launch 10 Nov 2022 · costs from the KID as of 2 Sept 2026 · 100 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of Solactive United States Technology 100 Equal Weight Index (the "Index"). The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a net total return index, meaning that dividends net of tax paid by the index constituents are included in the Index return. The Index is an equity broad-based, equal weight index that measures the performance of the largest 100 companies from the…
Performance since series start (in euro) — base 100
10 Nov 2022 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +24.3% |
| 3 years | +48.5% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +61.6% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 16.61% | 17.45% | — |
| Max drawdown | −10.61% | −20.84% | — |
| Sharpe | 1.14 | 0.75 | — |
| Sortino | 1.67 | 1.10 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · WEBA · IE000Y9MG9961
RebalixWEBA · IE000Y9MG996 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +13.58% | +13.45% | +0.13% |
| 2024 | +8.84% | +8.70% | +0.15% |
Distributions · per share, in USD
Frequency: annual · last 12 months: 0.126 USD (0.68% of NAV) · last ex-date 10 Feb 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 1 | 0.126 | — |
| 2025 | 1 | 0.106 | +0.77% |
| 2024 | 1 | 0.0962 | +0.75% |
| 2023 | 1 | 0.0072 | +0.08% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 100 securities · top-10 weight = 11.4%
| Top holdings | Weight |
|---|---|
| 1.2% | |
| 1.2% | |
| 1.2% | |
| 1.2% | |
| 1.2% | |
| 1.1% | |
| 1.1% | |
| 1.1% | |
| 1.1% | |
| 1.1% |
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
WEBA · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 15 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE000Y9MG996
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE000Y9MG996
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · WEBA · IE000Y9MG9962